semaglutide with low bmi Effect of 2.4 mg once weekly on 10‐year type 2 diabetes risk in adults overweight or obesity - Wilkinson - 2023 - Obesity The Pros and Cons of

The results of these studies will give us tremendous insight into how GLP-1s work in the brain and potentially broaden and distinguish the therapeutic benefits of this class from the weight loss/appetite suppression mechanism, opening the addressable patient population for this class of medicines beyond comorbid T2D and Obesity conditions

To ensure safety and efficacy: Consult a concierge physician to develop a personalized treatment plan

(A Simple Explanation) For fats to be burned for energy, they need to get inside the cell's furnace, the mitochondria

doi:10.1016/j.biopha.2020.110218 54

No large-scale, randomized controlled trial has been specifically designed to study hair loss as a primary outcome of GLP-1 therapy